Industry Updates for the Psychedelics World

Psychedelics News

Industry

20 Dec 2023

Terran Biosciences Receives FDA Clearance for MRI Scan Technology

Terran Biosciences Receives FDA Clearance for NM-101, the industry’s first software for the analysis of neuromelanin-sensitive MRI...

By Microdose NewsDesk

Industry

15 Dec 2023

Kanna: The Power of Plants for Conscious Evolution

In a recent interview with the Mindfulness Experience podcast, Keith Fiveson discussed the power of Kanna for conscious evolution....

By Keith Fiveson

Industry

6 Dec 2023

Cybin Granted U.S. Patent For CYB003 Psilocybin Program

New patent provides IP protection until at least 2041. Cybin’s patent portfolio now includes 39 granted patents and over 170 pending applications....

By Microdose NewsDesk

Industry

25 Oct 2023

Microdose Announces PsychMD as Wonderland 2023 Headline Sponsor

Taking this next step to lead the way into the future of wellness is a massive undertaking — one that wouldn’t be possible without the support of our sponsors. They...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

4 Oct 2023

GH Research: Updates on Clinical Development Programs

5-MEO-DMT developer GH Research has provided an update on its main clinical programs....

By Microdose NewsDesk

Industry

3 Oct 2023

atai Life Sciences Completes Phase 1 Study of Oral DMT

Atai Life Sciences has completed its Phase 1 study of VLS-01, an oral DMT for treatment-resistant depression (TRD)....

By Jason Najum

Industry

28 Sep 2023

Numinus Announces $10 Million Equity Program

Numinus has announced an at-the-market equity offering program that allows the company to issue and sell up to $10,000,000 (CAD) of common shares....

By Microdose NewsDesk

Industry

27 Sep 2023

FDA Accepts PharmaTher’s New Drug Application for KETARX™ (Ketamine)

The FDA has accepted the company’s Abbreviated New Drug Application for KETARX™ (racemic ketamine). The goal date for this priority original ANDA of April 29, 2024....

By Microdose NewsDesk

Industry

25 Sep 2023

TheraPsil Unveils MDMA-Assisted Psychotherapy Training Program

Non-profit TheraPsil announces launching of MDMA therapy training program....

By Microdose NewsDesk

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result